SCGB3A2 and pulmonary fibrosis: In contrast, another study by Kadur Lakshminarasimha Murthy and colleagues found that AEC2s can convert to SCGB3A2+ cells in organoid cultures and de novo in human lungs after injury and in diseases including idiopathic pulmonary fibrosis and COPD (70).